Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 17, 2022 at 12:21 am IST
Share
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TRY 1,736.27 million compared to TRY 754.66 million a year ago. Net income was TRY 249.49 million compared to TRY 51.12 million a year ago. Basic earnings per share from continuing operations was TRY 1 compared to TRY 0.2 a year ago.
For the six months, sales was TRY 2,968.05 million compared to TRY 1,560.9 million a year ago. Net income was TRY 417.58 million compared to TRY 134.12 million a year ago. Basic earnings per share from continuing operations was TRY 1.39 compared to TRY 0.54 a year ago.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is a Turkey-based company, which engages in manufacturing of pharmaceuticals and other health products. The Company operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The Company has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.